Activity of mecillinam against carbapenem-resistant Enterobacterales.
Cécile EmeraudAlexandre GodmerDelphine GirlichOcéane VanparisFériel MahamdiElodie CretonAgnès B JoussetThierry NaasRemy A BonninLaurent DortetPublished in: The Journal of antimicrobial chemotherapy (2022)
Mecillinam might be an alternative for the treatment of infections due to CRE, particularly UTIs, except for VIM and KPC producers and for M. morganii and Serratia spp species.